Quantum Cyber N.V. closed at $0.74 on Nov 4, up 2.65%, within 2.7% of its lowest close since Sep 11. Volume of 391.7K shares was 0.73× its 20-day average (below normal).
Split-adjusted performance: -42.4% over one month.
Short interest was 1.2M shares at the Oct 15 settlement, down 22.7% from the prior report (6.3% of float, 1.8 days to cover).
No reported quarters with price history yet.
Percentile among 420 companies (100 = best)
Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.
| Company | Price | Today | 6M | Rev. growth | Net margin | P/E | Mkt cap | |
|---|---|---|---|---|---|---|---|---|
| QUCYQuantum Cyber N.V | $0.7430 | +2.65% | — | — | — | — | $62.5M | |
| SPROSpero Therapeutics | $1.07 | +2.88% | −57.7% | −100.0% | — | 8.4 | $62.3M | Compare |
| GOSSGossamer Bio | $9.95 | +7.22% | −64.5% | −19.6% | 182.9% | — | $60.9M | Compare |
| TELOTelomir Pharmaceuticals | $0.8750 | −3.85% | −34.7% | — | — | — | $64.5M | Compare |
| XBITXBiotech | $1.95 | −2.01% | −23.5% | — | — | — | $59.5M | Compare |
| FBIOFortress Biotech | $1.97 | +1.55% | −22.7% | +14.0% | −13.2% | 0.6 | $65.7M | Compare |
| VRCAVerrica Pharmaceuticals | $3.46 | +5.02% | −59.0% | −53.8% | −224.4% | — | $59.4M | Compare |
| RNXTRenovoRx | $1.31 | +1.55% | +47.2% | +115.4% | −320.2% | — | $59.1M | Compare |
| RANIRani Therapeutics Holdings | $0.5728 | +3.06% | −40.3% | — | −432.7% | — | $66.1M | Compare |
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
